Poznámky k epizodě
For years, null trials of intermittent haemodialysis versus CRRT were read as proof the two are interchangeable. ICRAKI, a French trial in ventilated or shocked patients with AKI, failed to show intermittent dialysis noninferior. Day-90 mortality was higher, but the trial stopped early with no prespecified decision rule. We unpack the appeal to ignorance, truncation bias and HARKing, why the direction is more credible than the size, and why it supports the CRRT-first default in ANZ ICUs.

